These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. [A Case of Pathologically Complete Response in Ruptured Hepatocellular Carcinoma Treated with Transcatheter Arterial Embolization]. Yoshikawa T; Sakamoto H; Asakura R; Ogawa H; Hirano S Gan To Kagaku Ryoho; 2018 Dec; 45(13):2147-2149. PubMed ID: 30692313 [TBL] [Abstract][Full Text] [Related]
65. Clinical evaluation of transcatheter arterial embolization and one-shot chemotherapy in hepatocellular carcinoma. Soga K; Nomoto M; Ichida T; Aoyagi Y; Ozaki T; Ichida F Hepatogastroenterology; 1988 Jun; 35(3):116-20. PubMed ID: 2841214 [TBL] [Abstract][Full Text] [Related]
66. [The evaluation of the effect of transcatheter hepatic arterial embolization (T.A.E.) for hepatocellular carcinoma (H.C.C.). The assessment of efficacies of T.A.E. for the resected specimens in comparison with changes of medical imagings]. Matsuo H; Okazaki M Nihon Igaku Hoshasen Gakkai Zasshi; 1985 Sep; 45(9):1220-36. PubMed ID: 3005963 [No Abstract] [Full Text] [Related]
71. Transcatheter arterial embolization for bone metastases from hepatocellular carcinoma. Uemura A; Fujimoto H; Yasuda S; Osaka I; Goto N; Shinozaki M; Ito H Eur Radiol; 2001; 11(8):1457-62. PubMed ID: 11519558 [TBL] [Abstract][Full Text] [Related]
72. [Clinical evaluation of power Doppler sonography for the diagnosis of hepatocellular carcinoma]. Ohishi H; Hirai T; Yamada R; Hirohashi S; Honda N; Sakaguchi H; Matsuo N; Uchida H Nihon Igaku Hoshasen Gakkai Zasshi; 1996 May; 56(6):399-404. PubMed ID: 8710463 [TBL] [Abstract][Full Text] [Related]
73. Multidisciplinary approach to palliation of obstructive jaundice caused by a central hepatocellular carcinoma. Läuffer JM; Mai G; Berchtold D; Curti CG; Triller J; Baer HU Dig Surg; 1999; 16(6):531-6. PubMed ID: 10805558 [TBL] [Abstract][Full Text] [Related]
74. Treatment of small hepatocellular carcinomas. Dusheiko GM; Hobbs KE; Dick R; Burroughs AK Lancet; 1992 Aug; 340(8814):285-8. PubMed ID: 1353202 [TBL] [Abstract][Full Text] [Related]
75. [Therapeutic effect of TAE in patients with hepatocellular carcinoma using color Doppler imaging with intravenous ultrasound contrast agent]. Kimura M; Sato M; Shioyama Y; Hagihira T; Horihata K; Terada M; Kishi K; Tanaka K; Kawai N Nihon Igaku Hoshasen Gakkai Zasshi; 2000 May; 60(6):320-3. PubMed ID: 10860382 [TBL] [Abstract][Full Text] [Related]
76. [Usefulness of enhanced US by CO2 microbubbles for segmental-subsegmental TAE for hepatocellular carcinoma]. Ohno K; Fujita M; Nakamura T; Sato O; Maeda T Nihon Rinsho; 1998 Apr; 56(4):994-1000. PubMed ID: 9577623 [TBL] [Abstract][Full Text] [Related]
77. [Case report: primary hyperfractionated accelerated radiotherapy in a case of hepatocellular carcinoma (HCC)]. Friedrich F; Papsdorf K; Liebmann A; Wolf U; Lamesch P; Hildebrandt G Zentralbl Chir; 2007 Aug; 132(4):316-21. PubMed ID: 17724634 [TBL] [Abstract][Full Text] [Related]
78. A case report of transcatheter arterial embolization of cholestatic type of hepatoma. Takagi H; Yamada S; Abe T; Uehara M; Takezawa J; Nagamine T; Ichikawa K; Kobayashi S; Katakai S Gastroenterol Jpn; 1989 Jun; 24(3):315-9. PubMed ID: 2545503 [TBL] [Abstract][Full Text] [Related]
79. Prolonged recurrence-free survival following OK432-stimulated dendritic cell transfer into hepatocellular carcinoma during transarterial embolization. Nakamoto Y; Mizukoshi E; Kitahara M; Arihara F; Sakai Y; Kakinoki K; Fujita Y; Marukawa Y; Arai K; Yamashita T; Mukaida N; Matsushima K; Matsui O; Kaneko S Clin Exp Immunol; 2011 Feb; 163(2):165-77. PubMed ID: 21087443 [TBL] [Abstract][Full Text] [Related]
80. [Clinical experiences of LAK therapy in patients with hepatocellular carcinoma]. Zeki K; Sakamoto H; Okuno F; Sujita K; Eto S J UOEH; 1989 Sep; 11(3):341-5. PubMed ID: 2554458 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]